Header Logo

Connection

David Moore to Pneumococcal Vaccines

This is a "connection" page, showing publications David Moore has written about Pneumococcal Vaccines.
Connection Strength

1,149
  1. Respiratory viral and pneumococcal coinfection of the respiratory tract: implications of pneumococcal vaccination. Expert Rev Respir Med. 2012 Aug; 6(4):451-65.
    View in: PubMed
    Score: 0,340
  2. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting. Paediatr Int Child Health. 2020 02; 40(1):50-57.
    View in: PubMed
    Score: 0,137
  3. Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions. Vaccine. 2017 08 03; 35(34):4321-4329.
    View in: PubMed
    Score: 0,120
  4. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
    View in: PubMed
    Score: 0,116
  5. Hospitalization for Culture-confirmed Pulmonary Tuberculosis in the Era of Childhood Pneumococcal Conjugate Vaccine Immunization. Pediatr Infect Dis J. 2017 01; 36(1):e14-e21.
    View in: PubMed
    Score: 0,116
  6. Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case-control study. Thorax. 2015 Dec; 70(12):1149-55.
    View in: PubMed
    Score: 0,104
  7. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study. Clin Infect Dis. 2014 Sep 15; 59(6):808-18.
    View in: PubMed
    Score: 0,097
  8. Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study. Pediatr Infect Dis J. 2010 Dec; 29(12):1099-04.
    View in: PubMed
    Score: 0,076
  9. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J. 2015 Jan; 34(1):27-34.
    View in: PubMed
    Score: 0,025
  10. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS. 2011 Feb 20; 25(4):453-62.
    View in: PubMed
    Score: 0,019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.